Abametapir

185 interactions 129 explained in plain English 2 cited references

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Acetaminophen And Codeine Lurbinectedin Injection Avanafil Atorvastatin Atazanavir Aripiprazole

185 Major

All (185) Major (185)

Major

Abametapir Repaglinide Prandin® Explained Increased exposure of CYP3A4 substrate Details Abametapir Ribociclib Kisqali Explained Increased exposure of CYP3A4 substrate Details Abametapir Rifabutin Mycobutin Explained Increased exposure of CYP3A4 substrate Details Abametapir Rilpivirine Edurant Explained Increased exposure of CYP3A4 substrate Details Abametapir Riluzole Exservan Explained Increased exposure of CYP1A2 substrates Details Abametapir Rimegepant Nurtec Explained Increased exposure of CYP3A4 substrate Details Abametapir Ripretinib Qinlock Explained Increased exposure of CYP3A4 substrate Details Abametapir Rivaroxaban Xarelto Explained Increased exposure of CYP3A4 substrate Details Abametapir Rolapitant Varubi Explained Increased exposure of CYP3A4 substrate Details Abametapir Ropivacaine Explained Increased exposure of CYP1A2 substrates Details Abametapir Salmeterol Serevent Explained Increased exposure of CYP3A4 substrate Details Abametapir Saquinavir Explained Increased exposure of CYP3A4 substrate Details Abametapir Saxagliptin Onglyza Explained Increased exposure of CYP3A4 substrate Details Abametapir Selumetinib Koselugo Explained Increased exposure of CYP3A4 substrate Details Abametapir Simeprevir Olysio® Explained Increased exposure of CYP3A4 substrate Details Abametapir Sonidegib Odomzo Explained Increased exposure of CYP3A4 substrate Details Abametapir Sunitinib Sutent Explained Increased exposure of CYP3A4 substrate Details Abametapir Suvorexant Belsomra Explained Increased exposure of CYP3A4 substrate Details Abametapir Tacrolimus Astagraf Explained Increased exposure of CYP3A4 substrate Details Abametapir Tamoxifen Nolvadex® Explained Increased exposure of CYP3A4 substrate Details Abametapir Tazemetostat Tazverik Explained Increased exposure of CYP3A4 substrate Details Abametapir Telithromycin Explained Increased exposure of CYP3A4 substrate Details Abametapir Tezacaftor Explained Increased exposure of CYP3A4 substrate Details Abametapir Theophylline Accurbron® Explained Increased exposure of CYP1A2 substrates Details Abametapir Thiotepa Tepadina Explained Increased exposure of CYP3A4 substrate Details Abametapir Ticagrelor Brilinta Explained Increased exposure of CYP3A4 substrate Details Abametapir Trabectedin Yondelis Explained Increased exposure of CYP3A4 substrate Details Abametapir Trazodone Raldesy Explained Increased exposure of CYP3A4 substrate Details Abametapir Tucatinib Tukysa Explained Increased exposure of CYP3A4 substrate Details Abametapir Upadacitinib Rinvoq Explained Increased exposure of CYP3A4 substrate Details Abametapir Velpatasvir Explained Increased exposure of CYP3A4 substrate Details Abametapir Verapamil Calan Explained Increased exposure of CYP3A4 substrate Details Abametapir Vinblastine Velban® Explained Increased exposure of CYP3A4 substrate Details Abametapir Vincristine Marqibo Explained Increased exposure of CYP3A4 substrate Details Abametapir Vincristine Sulfate Liposome Marqibo Explained Increased exposure of CYP3A4 substrate Details Abametapir Vinorelbine Navelbine Explained Increased exposure of CYP3A4 substrate Details Abametapir Vorapaxar Zontivity Explained Increased exposure of CYP3A4 substrate Details Abametapir Voxelotor Oxbryta Explained Increased exposure of CYP3A4 substrate Details Abametapir Voxilaprevir Explained Increased exposure of CYP3A4 substrate Details Abametapir Warfarin Coumadin Explained Increased exposure of CYP1A2 substrates Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.